Kobylski, Lauren A. http://orcid.org/0000-0002-0035-0516
Arakelian, Miranda H.
Freeman, Marlene P.
Gaw, Margaret L.
Cohen, Lee S.
Vanderkruik, Rachel
Funding for this research was provided by:
Jeanne and Gerhard Andlinger Research Fund for Innovative Science at Massachusetts General Hospital
Article History
Received: 22 August 2023
Accepted: 9 February 2024
First Online: 23 February 2024
Declarations
:
: Lauren A. Kobylski, MPH, Miranda H. Arakelian, BA, Margaret L. Gaw, BA, and Rachel Vanderkruik, PhD, MSc have no conflicts of interest to disclose. Marlene P. Freeman, MD (as of 7/10/2023): Research Support: Dr. Freeman is an employee of Massachusetts General Hospital, and works with the MGH National Pregnancy Registry. MGH National Pregnancy Registry: Current Sponsors: Alkermes, Inc. (2016-Present); Eisai, Inc. (2022-Present); Johnson & Johnson/Janssen Pharmaceuticals, Inc (2019-Present); Otsuka America Pharmaceutical, Inc. (2008-Present); Sage Therapeutics (2019-Present); Supernus Pharmaceuticals (2021-Present); Teva Pharmaceutical Industries Ltd. (2018-Present). As an employee of MGH, Dr. Freeman works with the MGH CTNI, which has had research funding from multiple pharmaceutical companies and NIMH. Other Research Support: SAGE Therapeutics, JayMac. Advisory/Consulting, Data Safety Committees: Independent Data Safety and Monitoring Committees: Janssen (Johnson& Johnson), Novartis, Neurocrine; Advisory Boards: Eliem, Sage; Brainify; Everly Health; Tibi Health; Relmada; Beckley Psytech.Speaking/Honoraria: WebMD, Medscape, Pri-Med, Postpartum Support International. Royalty/patent, other income: Scale Royalties- through MGH Scale, The Massachusetts Female Reproductive Lifecycle and Hormones Questionnaire.Lee S. Cohen, MD (as of 1/20/2023): Research Support: Dr. Cohen is an employee of Massachusetts General Hospital, and works with the MGH National Pregnancy Registry. MGH National Pregnancy Registry: Current Sponsors: Alkermes, Inc. (2016-Present); Eisai, Inc. (2022-Present); Johnson & Johnson/Janssen Pharmaceuticals, Inc (2019-Present); Otsuka America Pharmaceutical, Inc. (2008-Present); Sage Therapeutics (2019-Present); Supernus Pharmaceuticals (2021-Present); Teva Pharmaceutical Industries Ltd. (2018-Present). As an employee of MGH, Dr. Cohen works with the MGH CTNI, which has had research funding from multiple pharmaceutical companies and NIMH. Other research support: National Institutes of Health; SAGE Therapeutics. Advisory/Consulting: None. Speaking/Honoraria: None. Royalty/patent, other income: None.